Avner Pancreatic Cancer Foundation is the only foundation exclusively dedicated to pancreatic cancer in Australia. It aims to support innovative, translational, quality research and programs within the pancreatic cancer field. The objectives of the Innovation grants are to:
- Support established scientists and/or early career researchers to develop preliminary data necessary to support pursuit of additional funding in subsequent years
- Encourage and retain talented skilled individuals in the field of pancreatic cancer.
Funding & Duration
Four seed funding grants of $100,000 each (GST exclusive) for one year are being made available to support innovative pancreatic cancer projects with a desire to increase interest and investment in pancreatic cancer research.
Eligibility
Multiple grant applications from a single institution will be considered. However:
- Research groups within the institution can only submit one grant application
- An investigator can only be first named PI on a single grant
Awardees of 2015 Innovation grants are ineligible to apply for innovation grant funding in 2016.
International collaborations by Australian research organisations are permitted and strongly supported by the foundation. This is conditional on:
- The Applicant (organisation) being an Australian organisation
- The PI residing in Australia
- No more than 25% of the funded research is conducted overseas – this includes subcontracted services
- IP will rest with the Australian research organisation and be in accordance with the Avner Foundation standard grant terms and conditions
Please refer to the Application Guidelines (PDF) for further details.
Submission Requirements & Internal Due Date
- Applications must be submitted for internal review by 22 July 2016
- The University’s Grant Application Cover Sheet must accompany your application
- Email: raohealth@adelaide.edu.au